Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.

Rendas-Baum R, Yang M, Gricar J, Wallenstein GV.

Appl Health Econ Health Policy. 2010;8(2):129-40. doi: 10.2165/11532210-000000000-00000.

PMID:
20175591
2.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
3.

Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA.

Expert Opin Pharmacother. 2002 Jul;3(7):979-91. Review.

PMID:
12083997
4.

Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.

Steiner M, Pearlstein T.

J Clin Psychiatry. 2000;61 Suppl 12:17-21. Review.

5.

The role of fluoxetine in the treatment of premenstrual dysphoric disorder.

Romano S, Judge R, Dillon J, Shuler C, Sundell K.

Clin Ther. 1999 Apr;21(4):615-33; discussion 613. Review.

PMID:
10363729
6.

Premenstrual syndrome in adolescents: diagnosis and treatment.

Rapkin AJ, Mikacich JA.

Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:132-7. Review.

PMID:
16641847
7.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
8.

SSRIs for premenstrual dysphoric disorder.

[No authors listed]

Drug Ther Bull. 2002 Sep;40(9):70-2. Review.

PMID:
12298224
9.

Treating premenstrual dysphoric disorder using serotonin agents.

Lin J, Thompson DS.

J Womens Health Gend Based Med. 2001 Oct;10(8):745-50. Review.

PMID:
11703886
10.

Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.

Silber TJ, Valadez-Meltzer A.

J Adolesc Health. 2005 Dec;37(6):518-25. Review.

PMID:
16310133
11.

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Halbreich U, Borenstein J, Pearlstein T, Kahn LS.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:1-23. Review.

PMID:
12892987
12.

Treatment of premenstrual disorders.

Kroll R, Rapkin AJ.

J Reprod Med. 2006 Apr;51(4 Suppl):359-70. Review.

PMID:
16734319
13.
14.
15.

Selective serotonin reuptake inhibitors and treatment of premenstrual dysphoric disorder.

Finfgeld DL.

Perspect Psychiatr Care. 2002 Apr-Jun;38(2):50-60. Review.

PMID:
12132631
16.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

PMID:
14524645
17.

Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Freeman EW.

Pharmacoeconomics. 2005;23(5):433-44. Review.

PMID:
15896095
18.

[Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].

Lenzinger E, Diamant K, Vytiska-Binstorfer E, Kasper S.

Nervenarzt. 1997 Sep;68(9):708-18. Review. German.

PMID:
9411273
19.

Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder.

Frackiewicz EJ, Shiovitz TM.

J Am Pharm Assoc (Wash). 2001 May-Jun;41(3):437-47. Review.

PMID:
11372908
20.

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. Review.

PMID:
16417420

Supplemental Content

Support Center